| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.91 | 0.002 | 0.917 | 5 Hydroxytryptamine release stimulant | 0.917 0.001 CID_5202 | CID_5202 | |
| 0.733 | 0.004 | 0.733 | 5 Hydroxytryptamine 1 agonist | 0.7 0.004 CID_5202 | ||
| 0.676 | 0.004 | 0.676 | 5 Hydroxytryptamine agonist | 0.629 0.004 CID_5202 | ||
| 0.641 | 0.003 | 0.641 | 5 Hydroxytryptamine 1E antagonist | 0.597 0.003 CID_5202 | ||
| 0.647 | 0.03 | 0.647 | Caspase 9 stimulant | 0.591 0.037 CID_5202 | ||
| 0.614 | 0.002 | 0.614 | 5 Hydroxytryptamine 2A agonist | 0.469 0.002 CID_5202 | ||
| 0.563 | 0.003 | 0.567 | 5 Hydroxytryptamine 1B agonist | 0.567 0.003 CID_5202 | CID_5202 | |
| 0.532 | 0.003 | 0.532 | 5 Hydroxytryptamine 5 antagonist | 0.344 0.004 CID_5202 | ||
| 0.529 | 0.003 | 0.529 | 5 Hydroxytryptamine 5A antagonist | 0.379 0.003 CID_5202 | ||
| 0.522 | 0.003 | 0.522 | 5 Hydroxytryptamine 1D antagonist | 0.35 0.004 CID_5202 | ||
| 0.505 | 0.01 | 0.519 | Psychostimulant | 0.519 0.009 CID_5202 | CID_5202 | |
| 0.509 | 0.019 | 0.573 | Interleukin antagonist | 0.573 0.014 CID_5202 | CID_5202 | |
| 0.49 | 0.002 | 0.54 | Myeloperoxidase inhibitor | 0.54 0.002 CID_5202 | CID_5202 | |
| 0.456 | 0.002 | 0.456 | 5 Hydroxytryptamine 3E antagonist | 0.438 0.002 CID_5202 | ||
| 0.439 | 0.005 | 0.439 | 5 Hydroxytryptamine 1 antagonist | 0.233 0.014 CID_5202 | ||
| 0.468 | 0.041 | 0.521 | Calcium channel L-type activator | 0.521 0.02 CID_5202 | CID_5202 | |
| 0.418 | 0.002 | 0.418 | 5 Hydroxytryptamine 7 agonist | 0.262 0.003 CID_5202 | ||
| 0.419 | 0.01 | 0.419 | 5 Hydroxytryptamine antagonist | 0.229 0.028 CID_5202 | ||
| 0.411 | 0.005 | 0.411 | 5 Hydroxytryptamine 2C antagonist | 0.241 0.013 CID_5202 | ||
| 0.401 | 0.004 | 0.401 | 5 Hydroxytryptamine 1B antagonist | 0.27 0.005 CID_5202 | ||
| 0.414 | 0.02 | 0.414 | Calcium channel activator | 0.363 0.042 CID_5202 | ||
| 0.45 | 0.062 | 0.45 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.445 0.064 CID_5202 | ||
| 0.431 | 0.049 | 0.581 | GABA C receptor rho-3 antagonist | 0.581 0.01 CID_5202 | CID_5202 | |
| 0.401 | 0.02 | 0.628 | Peroxidase inhibitor | 0.628 0.004 CID_5202 | CID_5202 | |
| 0.375 | 0.006 | 0.375 | 5 Hydroxytryptamine 1A antagonist | 0.188 0.016 CID_5202 | ||
| 0.37 | 0.002 | 0.413 | 5 Hydroxytryptamine 3A agonist | 0.413 0.002 CID_5202 | CID_5202 | |
| 0.372 | 0.01 | 0.372 | 5 Hydroxytryptamine 2B antagonist | 0.235 0.021 CID_5202 | ||
| 0.373 | 0.022 | 0.413 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.413 0.015 CID_5202 | CID_5202 | |
| 0.374 | 0.027 | 0.42 | Insulysin inhibitor | 0.42 0.019 CID_5202 | CID_5202 | |
| 0.384 | 0.04 | 0.384 | Aryl hydrocarbon receptor agonist | 0.328 0.053 CID_5202 | ||
| 0.377 | 0.034 | 0.384 | DNA damaging | 0.384 0.032 CID_5202 | CID_5202 | |
| 0.34 | 0.007 | 0.34 | Alpha 2b adrenoreceptor antagonist | 0.264 0.013 CID_5202 | ||
| 0.404 | 0.073 | 0.487 | 15-Lipoxygenase inhibitor | 0.487 0.043 CID_5202 | CID_5202 | |
| 0.337 | 0.012 | 0.362 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.362 0.009 CID_5202 | CID_5202 | |
| 0.356 | 0.035 | 0.399 | Superoxide dismutase inhibitor | 0.399 0.027 CID_5202 | CID_5202 | |
| 0.323 | 0.003 | 0.439 | Histamine N-methyltransferase inhibitor | 0.439 0.002 CID_5202 | CID_5202 | |
| 0.333 | 0.014 | 0.333 | 5 Hydroxytryptamine 2 antagonist | 0.202 0.03 CID_5202 | ||
| 0.319 | 0.008 | 0.343 | Nitric-oxide synthase stimulant | 0.343 0.005 CID_5202 | CID_5202 | |
| 0.316 | 0.023 | 0.317 | DNA methylase inhibitor | 0.317 0.023 CID_5202 | CID_5202 | |
| 0.332 | 0.044 | 0.341 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.341 0.04 CID_5202 | CID_5202 | |
| 0.289 | 0.006 | 0.289 | 5 Hydroxytryptamine 1F antagonist | 0.261 0.007 CID_5202 | ||
| 0.282 | 0.003 | 0.282 | 5 Hydroxytryptamine 2 agonist | 0.187 0.004 CID_5202 | ||
| 0.316 | 0.042 | 0.371 | Amyloid beta aggregation inhibitor | 0.371 0.03 CID_5202 | CID_5202 | |
| 0.282 | 0.012 | 0.282 | 5 Hydroxytryptamine 2A antagonist | 0.155 0.027 CID_5202 | ||
| 0.291 | 0.034 | 0.35 | Growth hormone agonist | 0.35 0.023 CID_5202 | CID_5202 | |
| 0.279 | 0.023 | 0.279 | Tumour necrosis factor antagonist | 0.166 0.081 CID_5202 | ||
| 0.294 | 0.041 | 0.312 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.312 0.035 CID_5202 | CID_5202 | |
| 0.251 | 0.002 | 0.251 | 5 Hydroxytryptamine 1D agonist | 0.21 0.003 CID_5202 | ||
| 0.253 | 0.006 | 0.279 | CF transmembrane conductance regulator agonist | 0.279 0.004 CID_5202 | CID_5202 | |
| 0.264 | 0.018 | 0.288 | NADPH oxidase inhibitor | 0.288 0.014 CID_5202 | CID_5202 | |
| 0.27 | 0.028 | 0.292 | Lipocortins synthesis antagonist | 0.292 0.023 CID_5202 | CID_5202 | |
| 0.261 | 0.019 | 0.292 | Neurotensin receptor agonist | 0.292 0.015 CID_5202 | CID_5202 | |
| 0.272 | 0.038 | 0.274 | DNA methyltransferase I inhibitor | 0.274 0.036 CID_5202 | CID_5202 | |
| 0.279 | 0.045 | 0.393 | Tyrosine 3 hydroxylase inhibitor | 0.393 0.009 CID_5202 | CID_5202 | |
| 0.245 | 0.013 | 0.27 | GABA C receptor rho-2 antagonist | 0.27 0.008 CID_5202 | CID_5202 | |
| 0.232 | 0.005 | 0.318 | Prolactin inhibitor | 0.318 0.003 CID_5202 | CID_5202 | |
| 0.239 | 0.012 | 0.239 | Alpha 2c adrenoreceptor antagonist | 0.188 0.02 CID_5202 | ||
| 0.316 | 0.089 | 0.316 | Vasodilator, peripheral | 0.305 0.094 CID_5202 | ||
| 0.233 | 0.008 | 0.233 | 5 Hydroxytryptamine 1A agonist | 0.145 0.011 CID_5202 | ||
| 0.34 | 0.124 | 0.373 | 5 Hydroxytryptamine release inhibitor | 0.373 0.097 CID_5202 | CID_5202 | |
| 0.223 | 0.007 | 0.281 | Adenylate cyclase stimulant | 0.281 0.003 CID_5202 | CID_5202 | |
| 0.227 | 0.014 | 0.265 | Toll-Like receptor 2 antagonist | 0.265 0.007 CID_5202 | CID_5202 | |
| 0.271 | 0.062 | 0.283 | Antiamyloidogenic | 0.283 0.058 CID_5202 | CID_5202 | |
| 0.214 | 0.006 | 0.216 | CYP2A6 inhibitor | 0.216 0.006 CID_5202 | CID_5202 | |
| 0.217 | 0.011 | 0.258 | Protein kinase C gamma inhibitor | 0.258 0.006 CID_5202 | CID_5202 | |
| 0.27 | 0.064 | 0.294 | 5 Hydroxytryptamine uptake stimulant | 0.294 0.048 CID_5202 | CID_5202 | |
| 0.206 | 0.002 | 0.206 | Melatonin receptor 1A agonist | 0.065 0.005 CID_5202 | ||
| 0.209 | 0.007 | 0.27 | GABA C receptor rho-1 antagonist | 0.27 0.004 CID_5202 | CID_5202 | |
| 0.207 | 0.006 | 0.609 | Phenylalanine 4-hydroxylase inhibitor | 0.609 0.002 CID_5202 | CID_5202 | |
| 0.213 | 0.012 | 0.213 | Alpha 2a adrenoreceptor antagonist | 0.18 0.017 CID_5202 | ||
| 0.199 | 0.003 | 0.27 | GABA B receptor agonist | 0.27 0.003 CID_5202 | CID_5202 | |
| 0.289 | 0.097 | 0.289 | Vasodilator, coronary | 0.258 0.127 CID_5202 | ||
| 0.206 | 0.017 | 0.206 | Alpha 2 adrenoreceptor antagonist | 0.149 0.027 CID_5202 | ||
| 0.229 | 0.052 | 0.259 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.259 0.043 CID_5202 | CID_5202 | |
| 0.23 | 0.053 | 0.23 | Sigma receptor agonist | 0.194 0.063 CID_5202 | ||
| 0.2 | 0.03 | 0.2 | Toll-Like receptor antagonist | 0.185 0.036 CID_5202 | ||
| 0.235 | 0.066 | 0.235 | Antimitotic | |||
| 0.195 | 0.028 | 0.195 | Alpha adrenoreceptor antagonist | 0.106 0.053 CID_5202 | ||
| 0.204 | 0.039 | 0.205 | MAO inhibitor | 0.205 0.039 CID_5202 | CID_5202 | |
| 0.185 | 0.021 | 0.233 | Carbonic anhydrase XV inhibitor | 0.233 0.014 CID_5202 | CID_5202 | |
| 0.181 | 0.017 | 0.3 | GABA C receptor antagonist | 0.3 0.004 CID_5202 | CID_5202 | |
| 0.172 | 0.009 | 0.172 | Toll-Like receptor 3 antagonist | 0.122 0.028 CID_5202 | ||
| 0.291 | 0.128 | 0.405 | Histamine release inhibitor | 0.405 0.073 CID_5202 | CID_5202 | |
| 0.166 | 0.004 | 0.166 | Melatonin agonist | 0.066 0.006 CID_5202 | ||
| 0.189 | 0.028 | 0.302 | Adenylate cyclase inhibitor | 0.302 0.013 CID_5202 | CID_5202 | |
| 0.165 | 0.004 | 0.221 | 5 Hydroxytryptamine 3 agonist | 0.221 0.004 CID_5202 | CID_5202 | |
| 0.182 | 0.024 | 0.182 | Falcipain 3 inhibitor | 0.164 0.03 CID_5202 | ||
| 0.18 | 0.025 | 0.386 | GABA C receptor agonist | 0.386 0.005 CID_5202 | CID_5202 | |
| 0.17 | 0.016 | 0.264 | Protein kinase C zeta inhibitor | 0.264 0.007 CID_5202 | CID_5202 | |
| 0.219 | 0.064 | 0.254 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.254 0.05 CID_5202 | CID_5202 | |
| 0.172 | 0.018 | 0.172 | Alpha 1b adrenoreceptor antagonist | 0.105 0.034 CID_5202 | ||
| 0.156 | 0.005 | 0.156 | 5 Hydroxytryptamine 6 antagonist | 0.105 0.013 CID_5202 | ||
| 0.175 | 0.026 | 0.175 | Beta amyloid protein antagonist | 0.134 0.053 CID_5202 | ||
| 0.165 | 0.017 | 0.165 | Nitric-oxide synthase inhibitor | 0.159 0.019 CID_5202 | ||
| 0.162 | 0.018 | 0.345 | Histidine decarboxylase inhibitor | 0.345 0.005 CID_5202 | CID_5202 | |
| 0.161 | 0.017 | 0.161 | 5 Hydroxytryptamine 7 antagonist | 0.088 0.028 CID_5202 | ||
| 0.189 | 0.046 | 0.189 | Vascular endothelial growth factor 3 antagonist | 0.118 0.097 CID_5202 | ||
| 0.157 | 0.015 | 0.165 | Alpha adrenoreceptor agonist | 0.165 0.014 CID_5202 | CID_5202 | |
| 0.154 | 0.013 | 0.191 | Somatostatin 1 agonist | 0.191 0.007 CID_5202 | CID_5202 | |
| 0.237 | 0.097 | 0.277 | Spasmolytic | 0.277 0.08 CID_5202 | CID_5202 | |
| 0.192 | 0.054 | 0.21 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.21 0.047 CID_5202 | CID_5202 | |
| 0.142 | 0.004 | 0.142 | Melatonin antagonist | 0.068 0.005 CID_5202 | ||
| 0.166 | 0.028 | 0.166 | GABA receptor agonist | 0.162 0.03 CID_5202 | ||
| 0.259 | 0.121 | 0.318 | Transcription factor NF kappa B inhibitor | 0.318 0.086 CID_5202 | CID_5202 | |
| 0.15 | 0.014 | 0.242 | Adrenaline agonist | 0.242 0.005 CID_5202 | CID_5202 | |
| 0.227 | 0.092 | 0.417 | Aldehyde oxidase inhibitor | 0.417 0.045 CID_5202 | CID_5202 | |
| 0.137 | 0.003 | 0.137 | 5 Hydroxytryptamine 2B agonist | 0.088 0.004 CID_5202 | ||
| 0.203 | 0.069 | 0.245 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.245 0.045 CID_5202 | CID_5202 | |
| 0.18 | 0.051 | 0.214 | Melanin inhibitor | 0.214 0.036 CID_5202 | CID_5202 | |
| 0.147 | 0.018 | 0.147 | Acetylcholine release stimulant | 0.11 0.066 CID_5202 | ||
| 0.167 | 0.038 | 0.167 | Nav1.6 sodium channel blocker | 0.14 0.066 CID_5202 | ||
| 0.181 | 0.053 | 0.214 | Death-associated protein kinase 2 inhibitor | 0.214 0.026 CID_5202 | CID_5202 | |
| 0.172 | 0.046 | 0.172 | Nav1.2 sodium channel blocker | 0.143 0.061 CID_5202 | ||
| 0.211 | 0.089 | 0.333 | Free radical scavenger | 0.333 0.043 CID_5202 | CID_5202 | |
| 0.156 | 0.034 | 0.169 | Heat shock protein 70 antagonist | 0.169 0.018 CID_5202 | CID_5202 | |
| 0.13 | 0.011 | 0.13 | Alpha 1 adrenoreceptor agonist | 0.1 0.017 CID_5202 | ||
| 0.141 | 0.026 | 0.226 | DOPA decarboxylase inhibitor | 0.226 0.004 CID_5202 | CID_5202 | |
| 0.195 | 0.08 | 0.218 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.218 0.063 CID_5202 | CID_5202 | |
| 0.134 | 0.02 | 0.134 | Inducible nitric-oxide synthase inhibitor | 0.124 0.023 CID_5202 | ||
| 0.14 | 0.026 | 0.166 | Protein kinase C delta inhibitor | 0.166 0.015 CID_5202 | CID_5202 | |
| 0.117 | 0.004 | 0.117 | Melatonin 1 agonist | 0.067 0.005 CID_5202 | ||
| 0.147 | 0.035 | 0.184 | Nav1.4 sodium channel blocker | 0.184 0.023 CID_5202 | CID_5202 | |
| 0.14 | 0.028 | 0.14 | Breast cancer-resistant protein inhibitor | 0.101 0.054 CID_5202 | ||
| 0.124 | 0.012 | 0.124 | Bombesin 1 receptor agonist | 0.12 0.013 CID_5202 | ||
| 0.12 | 0.01 | 0.149 | Beta 3 adrenoreceptor antagonist | 0.149 0.006 CID_5202 | CID_5202 | |
| 0.203 | 0.093 | 0.27 | Angiogenesis stimulant | 0.27 0.061 CID_5202 | CID_5202 | |
| 0.162 | 0.052 | 0.162 | Tubulin antagonist | |||
| 0.126 | 0.018 | 0.126 | Alpha 1d adrenoreceptor antagonist | 0.064 0.038 CID_5202 | ||
| 0.108 | 0.002 | 0.108 | 5 Hydroxytryptamine 6 agonist | 0.1 0.003 CID_5202 | ||
| 0.136 | 0.032 | 0.136 | Alpha 1 adrenoreceptor antagonist | |||
| 0.173 | 0.071 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.136 0.128 CID_5202 | ||
| 0.177 | 0.075 | 0.194 | LIM domain kinase 1 inhibitor | 0.194 0.066 CID_5202 | CID_5202 | |
| 0.127 | 0.027 | 0.158 | Aminoacyl-tRNA synthetase inhibitor | 0.158 0.017 CID_5202 | CID_5202 | |
| 0.139 | 0.039 | 0.151 | Photosensitizer | 0.151 0.03 CID_5202 | CID_5202 | |
| 0.123 | 0.024 | 0.125 | Protein kinase B gamma inhibitor | 0.125 0.024 CID_5202 | CID_5202 | |
| 0.104 | 0.006 | 0.104 | Growth hormone secretagogue receptor antagonist | 0.076 0.01 CID_5202 | ||
| 0.125 | 0.028 | 0.217 | Carbonic anhydrase VI inhibitor | 0.217 0.011 CID_5202 | CID_5202 | |
| 0.117 | 0.021 | 0.117 | 5 Hydroxytryptamine uptake inhibitor | 0.089 0.03 CID_5202 | ||
| 0.103 | 0.007 | 0.103 | Cyclin D1 inhibitor | 0.082 0.016 CID_5202 | ||
| 0.099 | 0.004 | 0.099 | Melatonin 2 agonist | 0.058 0.008 CID_5202 | ||
| 0.114 | 0.022 | 0.161 | Dopamine agonist | 0.161 0.014 CID_5202 | CID_5202 | |
| 0.204 | 0.112 | 0.237 | Neuropeptide Y2 antagonist | 0.237 0.069 CID_5202 | CID_5202 | |
| 0.216 | 0.125 | 0.219 | Gastrin inhibitor | 0.219 0.121 CID_5202 | CID_5202 | |
| 0.105 | 0.014 | 0.127 | Beta adrenoreceptor antagonist | 0.127 0.009 CID_5202 | CID_5202 | |
| 0.098 | 0.008 | 0.172 | Somatostatin agonist | 0.172 0.005 CID_5202 | CID_5202 | |
| 0.164 | 0.075 | 0.178 | Protein kinase (CK1) gamma 3 inhibitor | 0.178 0.062 CID_5202 | CID_5202 | |
| 0.142 | 0.053 | 0.142 | Antibacterial (Helicobacter pylori) | 0.138 0.058 CID_5202 | ||
| 0.097 | 0.011 | 0.116 | Beta 1 adrenoreceptor antagonist | 0.116 0.008 CID_5202 | CID_5202 | |
| 0.148 | 0.061 | 0.163 | Neurotrophic factor | 0.163 0.049 CID_5202 | CID_5202 | |
| 0.125 | 0.04 | 0.142 | Urease inhibitor | 0.142 0.027 CID_5202 | CID_5202 | |
| 0.089 | 0.005 | 0.089 | Histamine H2 receptor agonist | 0.084 0.006 CID_5202 | ||
| 0.151 | 0.068 | 0.183 | Protein kinase stimulant | 0.183 0.049 CID_5202 | CID_5202 | |
| 0.087 | 0.005 | 0.087 | GHS receptor agonist | 0.081 0.006 CID_5202 | ||
| 0.151 | 0.069 | 0.175 | Protein kinase C nu inhibitor | 0.175 0.058 CID_5202 | CID_5202 | |
| 0.125 | 0.043 | 0.125 | Antiadrenergic | 0.103 0.054 CID_5202 | ||
| 0.129 | 0.048 | 0.141 | MAO A inhibitor | 0.141 0.044 CID_5202 | CID_5202 | |
| 0.086 | 0.006 | 0.1 | Somatostatin 5 agonist | 0.1 0.005 CID_5202 | CID_5202 | |
| 0.176 | 0.096 | 0.224 | Pyruvate kinase inhibitor | 0.224 0.069 CID_5202 | CID_5202 | |
| 0.107 | 0.027 | 0.107 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.06 CID_5202 | ||
| 0.112 | 0.033 | 0.112 | Acetylcholine nicotinic antagonist | 0.104 0.037 CID_5202 | ||
| 0.083 | 0.004 | 0.083 | Melatonin 1 antagonist | 0.029 0.007 CID_5202 | ||
| 0.086 | 0.01 | 0.086 | 5 Hydroxytryptamine 4 antagonist | 0.059 0.025 CID_5202 | ||
| 0.119 | 0.044 | 0.119 | Adrenaline antagonist | 0.097 0.055 CID_5202 | ||
| 0.105 | 0.03 | 0.105 | Histamine H2 receptor antagonist | 0.087 0.051 CID_5202 | ||
| 0.12 | 0.045 | 0.2 | Carbonic anhydrase III inhibitor | 0.2 0.016 CID_5202 | CID_5202 | |
| 0.079 | 0.006 | 0.114 | GABA B receptor antagonist | 0.114 0.005 CID_5202 | CID_5202 | |
| 0.111 | 0.039 | 0.131 | Protein kinase A inhibitor | 0.131 0.03 CID_5202 | CID_5202 | |
| 0.097 | 0.025 | 0.097 | Neuronal nicotinic receptor antagonist | 0.09 0.029 CID_5202 | ||
| 0.09 | 0.018 | 0.097 | GABA receptor antagonist | 0.097 0.016 CID_5202 | CID_5202 | |
| 0.192 | 0.121 | 0.192 | Calpain inhibitor | 0.19 0.123 CID_5202 | ||
| 0.09 | 0.019 | 0.09 | Aryl hydrocarbon receptor antagonist | 0.082 0.025 CID_5202 | ||
| 0.08 | 0.009 | 0.101 | Somatostatin 1 antagonist | 0.101 0.007 CID_5202 | CID_5202 | |
| 0.124 | 0.054 | 0.144 | TRPA1 agonist | 0.144 0.035 CID_5202 | CID_5202 | |
| 0.091 | 0.022 | 0.091 | 5 Hydroxytryptamine 3A antagonist | 0.062 0.052 CID_5202 | ||
| 0.074 | 0.005 | 0.08 | Bombesin 1 receptor antagonist | 0.08 0.004 CID_5202 | CID_5202 | |
| 0.144 | 0.075 | 0.174 | Hemostatic | 0.174 0.046 CID_5202 | CID_5202 | |
| 0.08 | 0.012 | 0.089 | Cholecystokinin A antagonist | 0.089 0.01 CID_5202 | CID_5202 | |
| 0.081 | 0.014 | 0.081 | Calcium channel P-type blocker | |||
| 0.076 | 0.009 | 0.084 | Adenylate cyclase 1 inhibitor | 0.084 0.007 CID_5202 | CID_5202 | |
| 0.146 | 0.079 | 0.175 | Phospholipase A2 inhibitor | 0.175 0.057 CID_5202 | CID_5202 | |
| 0.115 | 0.048 | 0.173 | Adenylate kinase inhibitor | 0.173 0.02 CID_5202 | CID_5202 | |
| 0.083 | 0.016 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.072 0.02 CID_5202 | ||
| 0.132 | 0.065 | 0.132 | Cyclooxygenase 3 inhibitor | 0.13 0.067 CID_5202 | ||
| 0.089 | 0.022 | 0.106 | Carbonic anhydrase stimulant | 0.106 0.017 CID_5202 | CID_5202 | |
| 0.07 | 0.003 | 0.07 | Melatonin receptor 1A antagonist | |||
| 0.08 | 0.014 | 0.08 | Histamine agonist | 0.063 0.025 CID_5202 | ||
| 0.123 | 0.057 | 0.182 | Interleukin 8 antagonist | 0.182 0.018 CID_5202 | CID_5202 | |
| 0.142 | 0.076 | 0.142 | CDC-like kinase 1 inhibitor | 0.119 0.096 CID_5202 | ||
| 0.073 | 0.009 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.077 0.007 CID_5202 | CID_5202 | |
| 0.207 | 0.144 | 0.219 | Hypoxia-inducible factor 1 alpha inhibitor | 0.219 0.13 CID_5202 | CID_5202 | |
| 0.096 | 0.034 | 0.096 | Dopamine D2 antagonist | 0.072 0.043 CID_5202 | ||
| 0.099 | 0.037 | 0.099 | Alpha 1a adrenoreceptor antagonist | |||
| 0.143 | 0.081 | 0.182 | Acetylcholine M1 receptor antagonist | 0.182 0.051 CID_5202 | CID_5202 | |
| 0.207 | 0.146 | 0.213 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.213 0.131 CID_5202 | CID_5202 | |
| 0.113 | 0.052 | 0.15 | Beta glucuronidase inhibitor | 0.15 0.025 CID_5202 | CID_5202 | |
| 0.078 | 0.018 | 0.096 | Bombesin 2 receptor antagonist | 0.096 0.014 CID_5202 | CID_5202 | |
| 0.111 | 0.053 | 0.111 | Butyrylcholinesterase inhibitor | |||
| 0.097 | 0.04 | 0.097 | Dopamine antagonist | 0.077 0.049 CID_5202 | ||
| 0.112 | 0.054 | 0.112 | MAO B inhibitor | 0.112 0.054 CID_5202 | ||
| 0.067 | 0.009 | 0.085 | Somatostatin 5 antagonist | 0.085 0.008 CID_5202 | CID_5202 | |
| 0.167 | 0.11 | 0.167 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.132 CID_5202 | ||
| 0.11 | 0.053 | 0.11 | Bronchodilator | 0.106 0.057 CID_5202 | ||
| 0.097 | 0.04 | 0.097 | Factor XII inhibitor | 0.091 0.048 CID_5202 | ||
| 0.067 | 0.01 | 0.092 | Somatostatin 2 antagonist | 0.092 0.007 CID_5202 | CID_5202 | |
| 0.137 | 0.081 | 0.142 | MAP3K9 inhibitor | 0.142 0.073 CID_5202 | CID_5202 | |
| 0.106 | 0.05 | 0.155 | HIV-1 integrase (Overall Integration) inhibitor | 0.155 0.023 CID_5202 | CID_5202 | |
| 0.167 | 0.111 | 0.18 | Insulin sensitizer | 0.18 0.095 CID_5202 | CID_5202 | |
| 0.068 | 0.015 | 0.076 | Cholecystokinin antagonist | 0.076 0.012 CID_5202 | CID_5202 | |
| 0.078 | 0.025 | 0.096 | Alpha 2 adrenoreceptor agonist | 0.096 0.016 CID_5202 | CID_5202 | |
| 0.071 | 0.018 | 0.094 | Beta 2 adrenoreceptor agonist | 0.094 0.005 CID_5202 | CID_5202 | |
| 0.066 | 0.013 | 0.086 | Growth hormone release inhibitor | 0.086 0.008 CID_5202 | CID_5202 | |
| 0.086 | 0.033 | 0.121 | MAP kinase kinase 7 inhibitor | 0.121 0.004 CID_5202 | CID_5202 | |
| 0.105 | 0.053 | 0.132 | Pim-1 kinase inhibitor | 0.132 0.035 CID_5202 | CID_5202 | |
| 0.057 | 0.005 | 0.057 | Follicle-stimulating hormone agonist | 0.039 0.008 CID_5202 | ||
| 0.057 | 0.005 | 0.057 | GHS receptor antagonist | 0.047 0.008 CID_5202 | ||
| 0.075 | 0.024 | 0.076 | GABA A receptor antagonist | 0.076 0.023 CID_5202 | CID_5202 | |
| 0.062 | 0.011 | 0.171 | Dopamine D5 agonist | 0.171 0.002 CID_5202 | CID_5202 | |
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | 0.055 0.053 CID_5202 | ||
| 0.076 | 0.026 | 0.076 | 5 Hydroxytryptamine 3 antagonist | 0.05 0.049 CID_5202 | ||
| 0.068 | 0.018 | 0.094 | Beta 2 adrenoreceptor antagonist | 0.094 0.009 CID_5202 | CID_5202 | |
| 0.06 | 0.011 | 0.06 | 5 Hydroxytryptamine 3B antagonist | 0.044 0.017 CID_5202 | ||
| 0.071 | 0.022 | 0.071 | Protein kinase C theta inhibitor | 0.07 0.023 CID_5202 | ||
| 0.139 | 0.091 | 0.184 | Thrombolytic | 0.184 0.06 CID_5202 | CID_5202 | |
| 0.066 | 0.018 | 0.109 | Dopamine D2 agonist | 0.109 0.01 CID_5202 | CID_5202 | |
| 0.14 | 0.092 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.143 0.086 CID_5202 | CID_5202 | |
| 0.063 | 0.016 | 0.069 | Bombesin antagonist | 0.069 0.013 CID_5202 | CID_5202 | |
| 0.064 | 0.018 | 0.064 | 5 Hydroxytryptamine 2C agonist | 0.057 0.023 CID_5202 | ||
| 0.206 | 0.16 | 0.206 | Caspase 3 stimulant | 0.192 0.182 CID_5202 | ||
| 0.137 | 0.092 | 0.17 | MAP kinase kinase 4 inhibitor | 0.17 0.033 CID_5202 | CID_5202 | |
| 0.095 | 0.05 | 0.287 | NMDA receptor antagonist | 0.287 0.007 CID_5202 | CID_5202 | |
| 0.056 | 0.011 | 0.056 | Histamine H1 receptor agonist | 0.056 0.012 CID_5202 | ||
| 0.127 | 0.083 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 CID_5202 | CID_5202 | |
| 0.054 | 0.012 | 0.054 | Diamine oxidase inhibitor | 0.036 0.028 CID_5202 | ||
| 0.107 | 0.065 | 0.157 | Topoisomerase I inhibitor | 0.157 0.039 CID_5202 | CID_5202 | |
| 0.094 | 0.052 | 0.133 | Antineoplastic alkaloid | 0.133 0.033 CID_5202 | CID_5202 | |
| 0.061 | 0.02 | 0.063 | Melanocortin antagonist | 0.063 0.019 CID_5202 | CID_5202 | |
| 0.12 | 0.078 | 0.12 | Acetylcholinesterase inhibitor | |||
| 0.067 | 0.026 | 0.078 | Protein kinase C epsilon inhibitor | 0.078 0.02 CID_5202 | CID_5202 | |
| 0.086 | 0.045 | 0.129 | Macrophage migration inhibitory factor inhibitor | 0.129 0.022 CID_5202 | CID_5202 | |
| 0.155 | 0.115 | 0.182 | Death-associated protein kinase 3 inhibitor | 0.182 0.086 CID_5202 | CID_5202 | |
| 0.058 | 0.018 | 0.08 | Dopamine beta hydroxylase inhibitor | 0.08 0.005 CID_5202 | CID_5202 | |
| 0.054 | 0.014 | 0.09 | Somatostatin 4 agonist | 0.09 0.007 CID_5202 | CID_5202 | |
| 0.16 | 0.12 | 0.168 | Growth factor agonist | 0.168 0.106 CID_5202 | CID_5202 | |
| 0.066 | 0.026 | 0.184 | NMDA 2A receptor antagonist | 0.184 0.005 CID_5202 | CID_5202 | |
| 0.087 | 0.047 | 0.113 | Glycine receptor antagonist | 0.113 0.022 CID_5202 | CID_5202 | |
| 0.047 | 0.008 | 0.058 | Dopamine autoreceptor agonist | 0.058 0.006 CID_5202 | CID_5202 | |
| 0.067 | 0.029 | 0.075 | Prolactin release inhibitor | 0.075 0.015 CID_5202 | CID_5202 | |
| 0.067 | 0.029 | 0.071 | Gonadotropin-releasing hormone receptor agonist | 0.071 0.024 CID_5202 | CID_5202 | |
| 0.097 | 0.06 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | 0.125 0.026 CID_5202 | CID_5202 | |
| 0.157 | 0.12 | 0.157 | Focal adhesion kinase 2 inhibitor | |||
| 0.088 | 0.051 | 0.088 | GABA A receptor agonist | 0.078 0.067 CID_5202 | ||
| 0.173 | 0.137 | 0.286 | Immunostimulant | 0.286 0.083 CID_5202 | CID_5202 | |
| 0.113 | 0.079 | 0.187 | Aldehyde dehydrogenase inhibitor | 0.187 0.031 CID_5202 | CID_5202 | |
| 0.153 | 0.119 | 0.187 | MAP kinase kinase 2 inhibitor | 0.187 0.091 CID_5202 | CID_5202 | |
| 0.075 | 0.042 | 0.082 | I kappa B kinase 1 inhibitor | 0.082 0.035 CID_5202 | CID_5202 | |
| 0.053 | 0.022 | 0.054 | Melanocortin 4 antagonist | 0.054 0.021 CID_5202 | CID_5202 | |
| 0.104 | 0.072 | 0.104 | EphA2 antagonist | |||
| 0.086 | 0.054 | 0.096 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.096 0.042 CID_5202 | CID_5202 | |
| 0.05 | 0.018 | 0.075 | Beta adrenoreceptor agonist | 0.075 0.005 CID_5202 | CID_5202 | |
| 0.172 | 0.14 | 0.279 | Antioxidant | 0.279 0.07 CID_5202 | CID_5202 | |
| 0.034 | 0.003 | 0.034 | Melatonin 2 antagonist | |||
| 0.036 | 0.004 | 0.036 | Follicle-stimulating hormone antagonist | 0.031 0.005 CID_5202 | ||
| 0.076 | 0.045 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.043 CID_5202 | CID_5202 | |
| 0.075 | 0.044 | 0.087 | Protein kinase B alpha inhibitor | 0.087 0.037 CID_5202 | CID_5202 | |
| 0.05 | 0.019 | 0.05 | Dihydrofolate reductase inhibitor | |||
| 0.072 | 0.042 | 0.095 | Sirtuin 1 inhibitor | 0.095 0.025 CID_5202 | CID_5202 | |
| 0.07 | 0.04 | 0.105 | Dopamine D1 antagonist | 0.105 0.023 CID_5202 | CID_5202 | |
| 0.047 | 0.018 | 0.047 | TRPM8 blocker | 0.038 0.027 CID_5202 | ||
| 0.102 | 0.075 | 0.102 | CDC-like kinase 3 inhibitor | 0.094 0.093 CID_5202 | ||
| 0.046 | 0.019 | 0.053 | Carbonic anhydrase I stimulant | 0.053 0.015 CID_5202 | CID_5202 | |
| 0.145 | 0.118 | 0.205 | Phospholipase C inhibitor | 0.205 0.041 CID_5202 | CID_5202 | |
| 0.078 | 0.051 | 0.102 | Carbonic anhydrase XIII inhibitor | 0.102 0.037 CID_5202 | CID_5202 | |
| 0.058 | 0.032 | 0.072 | Pim-2 kinase inhibitor | 0.072 0.023 CID_5202 | CID_5202 | |
| 0.088 | 0.062 | 0.097 | Pim-3 kinase inhibitor | 0.097 0.048 CID_5202 | CID_5202 | |
| 0.036 | 0.01 | 0.06 | Somatostatin 4 antagonist | 0.06 0.007 CID_5202 | CID_5202 | |
| 0.098 | 0.073 | 0.138 | AMP-activated protein kinase stimulant | 0.138 0.036 CID_5202 | CID_5202 | |
| 0.145 | 0.119 | 0.145 | Clk dual-specificity kinase inhibitor | |||
| 0.155 | 0.133 | 0.155 | MAP kinase kinase 5 inhibitor | |||
| 0.124 | 0.102 | 0.14 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.14 0.083 CID_5202 | CID_5202 | |
| 0.043 | 0.021 | 0.053 | Cholecystokinin B agonist | 0.053 0.014 CID_5202 | CID_5202 | |
| 0.076 | 0.054 | 0.11 | Keratolytic | 0.11 0.025 CID_5202 | CID_5202 | |
| 0.044 | 0.022 | 0.048 | Melanocortin 1 antagonist | 0.048 0.02 CID_5202 | CID_5202 | |
| 0.071 | 0.05 | 0.217 | NMDA 2 receptor antagonist | 0.217 0.008 CID_5202 | CID_5202 | |
| 0.03 | 0.009 | 0.047 | Somatostatin 3 antagonist | 0.047 0.007 CID_5202 | CID_5202 | |
| 0.199 | 0.179 | 0.245 | Antithrombotic | 0.245 0.13 CID_5202 | CID_5202 | |
| 0.055 | 0.036 | 0.055 | Toll-Like receptor 8 antagonist | |||
| 0.062 | 0.043 | 0.078 | Histone deacetylase SIRT3 inhibitor | 0.078 0.02 CID_5202 | CID_5202 | |
| 0.153 | 0.133 | 0.192 | Dyrk kinase inhibitor | 0.192 0.103 CID_5202 | CID_5202 | |
| 0.223 | 0.204 | 0.34 | Antibacterial | 0.34 0.108 CID_5202 | CID_5202 | |
| 0.074 | 0.055 | 0.1 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.1 0.035 CID_5202 | CID_5202 | |
| 0.199 | 0.18 | 0.256 | Apoptosis antagonist | 0.256 0.122 CID_5202 | CID_5202 | |
| 0.028 | 0.009 | 0.028 | 5 Hydroxytryptamine 4 agonist | |||
| 0.062 | 0.043 | 0.062 | Dopamine D3 antagonist | |||
| 0.028 | 0.009 | 0.028 | Melatonin 3 antagonist | 0.019 0.013 CID_5202 | ||
| 0.149 | 0.13 | 0.149 | Platelet aggregation inhibitor | |||
| 0.118 | 0.1 | 0.134 | Protein kinase (CK1) gamma 1 inhibitor | 0.134 0.083 CID_5202 | CID_5202 | |
| 0.059 | 0.042 | 0.059 | Dopamine D4 antagonist | |||
| 0.09 | 0.073 | 0.113 | Interleukin 12 antagonist | 0.113 0.036 CID_5202 | CID_5202 | |
| 0.061 | 0.044 | 0.12 | NMDA 2C receptor antagonist | 0.12 0.01 CID_5202 | CID_5202 | |
| 0.066 | 0.049 | 0.095 | Check point kinase 1 inhibitor | 0.095 0.03 CID_5202 | CID_5202 | |
| 0.11 | 0.094 | 0.138 | Glycogen synthase kinase-3 alpha inhibitor | 0.138 0.074 CID_5202 | CID_5202 | |
| 0.071 | 0.055 | 0.071 | Rho-associated kinase I inhibitor | |||
| 0.037 | 0.02 | 0.037 | Growth hormone releasing factor agonist | 0.037 0.02 CID_5202 | ||
| 0.041 | 0.025 | 0.041 | Leukotriene A4 hydrolase inhibitor | 0.038 0.026 CID_5202 | ||
| 0.076 | 0.061 | 0.076 | Platelet growth factor antagonist | |||
| 0.052 | 0.036 | 0.053 | Carbonic anhydrase II stimulant | 0.053 0.034 CID_5202 | CID_5202 | |
| 0.023 | 0.007 | 0.025 | Somatostatin 3 agonist | 0.025 0.005 CID_5202 | CID_5202 | |
| 0.033 | 0.019 | 0.04 | Cholecystokinin B antagonist | 0.04 0.014 CID_5202 | CID_5202 | |
| 0.026 | 0.011 | 0.041 | Beta 1 adrenoreceptor agonist | 0.041 0.005 CID_5202 | CID_5202 | |
| 0.061 | 0.047 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 CID_5202 | CID_5202 | |
| 0.03 | 0.015 | 0.035 | Urotensin II agonist | 0.035 0.012 CID_5202 | CID_5202 | |
| 0.16 | 0.146 | 0.16 | Tumour necrosis factor alpha release inhibitor | |||
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 CID_5202 | ||
| 0.057 | 0.044 | 0.1 | CXC chemokine 4 receptor antagonist | 0.1 0.025 CID_5202 | CID_5202 | |
| 0.04 | 0.027 | 0.04 | Substance P antagonist | |||
| 0.08 | 0.067 | 0.099 | Estrogen-related receptor beta agonist | 0.099 0.026 CID_5202 | CID_5202 | |
| 0.095 | 0.082 | 0.095 | Polo-like kinase-4 inhibitor | |||
| 0.023 | 0.011 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | Dopamine D3 agonist | 0.035 0.034 CID_5202 | ||
| 0.045 | 0.034 | 0.054 | Endothelin-converting enzyme inhibitor | 0.054 0.028 CID_5202 | CID_5202 | |
| 0.022 | 0.012 | 0.022 | Cholecystokinin agonist | 0.019 0.013 CID_5202 | ||
| 0.069 | 0.059 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.048 CID_5202 | CID_5202 | |
| 0.019 | 0.009 | 0.019 | Cholecystokinin A agonist | 0.015 0.012 CID_5202 | ||
| 0.017 | 0.008 | 0.029 | Somatostatin 2 agonist | 0.029 0.005 CID_5202 | CID_5202 | |
| 0.085 | 0.076 | 0.085 | Glutamate release inhibitor | |||
| 0.167 | 0.159 | 0.21 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 CID_5202 | CID_5202 | |
| 0.059 | 0.053 | 0.059 | Fibroblast growth factor 2 antagonist | |||
| 0.026 | 0.019 | 0.026 | Sigma 2 receptor antagonist | 0.023 0.021 CID_5202 | ||
| 0.018 | 0.013 | 0.018 | Histamine H4 receptor agonist | 0.017 0.015 CID_5202 | ||
| 0.051 | 0.045 | 0.059 | Bombesin 3 receptor antagonist | 0.059 0.034 CID_5202 | CID_5202 | |
| 0.051 | 0.046 | 0.052 | Epithelial sodium channel blocker | 0.052 0.043 CID_5202 | CID_5202 | |
| 0.112 | 0.108 | 0.114 | Vanilloid 1 agonist | 0.114 0.102 CID_5202 | CID_5202 | |
| 0.045 | 0.04 | 0.045 | Benzodiazepine antagonist | |||
| 0.11 | 0.105 | 0.11 | Interleukin 1 antagonist | |||
| 0.142 | 0.138 | 0.183 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.183 0.104 CID_5202 | CID_5202 | |
| 0.061 | 0.058 | 0.08 | Carbonic anhydrase VA inhibitor | 0.08 0.036 CID_5202 | CID_5202 | |
| 0.024 | 0.02 | 0.028 | Melanocortin 5 antagonist | 0.028 0.017 CID_5202 | CID_5202 | |
| 0.021 | 0.017 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.033 | 0.03 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.027 CID_5202 | CID_5202 | |
| 0.137 | 0.134 | 0.137 | I kappa B kinase epsilon inhibitor | |||
| 0.029 | 0.026 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 CID_5202 | CID_5202 | |
| 0.159 | 0.156 | 0.159 | ErbB-1 antagonist | |||
| 0.036 | 0.034 | 0.04 | Histone deacetylase 9 inhibitor | 0.04 0.025 CID_5202 | CID_5202 | |
| 0.066 | 0.064 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.077 | 0.075 | 0.108 | CC chemokine 5 receptor agonist | 0.108 0.014 CID_5202 | CID_5202 | |
| 0.057 | 0.055 | 0.058 | Neutrophil collagenase inhibitor | 0.058 0.053 CID_5202 | CID_5202 | |
| 0.073 | 0.072 | 0.106 | I kappa B kinase inhibitor | 0.106 0.034 CID_5202 | CID_5202 | |
| 0.017 | 0.016 | 0.017 | Growth hormone release promoting | 0.017 0.016 CID_5202 | ||
| 0.048 | 0.047 | 0.083 | Protein kinase C eta inhibitor | 0.083 0.022 CID_5202 | CID_5202 | |
| 0.121 | 0.12 | 0.121 | Neuropeptide Y1 antagonist | |||
| 0.233 | 0.233 | 0.258 | Apoptosis agonist | 0.258 0.206 CID_5202 | CID_5202 | |
| 0.02 | 0.02 | 0.033 | Dopamine D1 agonist | 0.033 0.008 CID_5202 | CID_5202 | |
| 0.032 | 0.032 | 0.073 | Kinesin-like protein 1 inhibitor | 0.073 0.012 CID_5202 | CID_5202 | |
| 0.032 | 0.032 | 0.073 | Kinesin antagonist | 0.073 0.012 CID_5202 | CID_5202 | |
| 0.064 | 0.064 | 0.156 | Glutamate decarboxylase inhibitor | 0.156 0.012 CID_5202 | CID_5202 | |
| 0.063 | 0.063 | 0.091 | Protein kinase C beta inhibitor | 0.091 0.019 CID_5202 | CID_5202 | |
| 0.02 | 0.021 | 0.021 | Bombesin agonist | 0.021 0.018 CID_5202 | CID_5202 | |
| 0.018 | 0.021 | 0.028 | Growth hormone releasing factor antagonist | 0.028 0.014 CID_5202 | CID_5202 | |
| 0.095 | 0.098 | 0.177 | M18 aspartyl aminopeptidase inhibitor | 0.177 0.041 CID_5202 | CID_5202 | |
| 0.091 | 0.095 | 0.097 | Protein kinase (CK1) gamma 2 inhibitor | 0.097 0.087 CID_5202 | CID_5202 | |
| 0.045 | 0.05 | 0.08 | Carbonic anhydrase VB inhibitor | 0.08 0.022 CID_5202 | CID_5202 | |
| 0.02 | 0.025 | 0.028 | Melanocortin 3 antagonist | 0.028 0.02 CID_5202 | CID_5202 | |
| 0.076 | 0.082 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 CID_5202 | CID_5202 | |
| 0.033 | 0.039 | 0.042 | Complement C3a chemotactic receptor antagonist | 0.042 0.031 CID_5202 | CID_5202 | |
| 0.078 | 0.084 | 0.161 | Aminopeptidase B inhibitor | 0.161 0.033 CID_5202 | CID_5202 | |
| 0.021 | 0.031 | 0.04 | Thyroid hormone agonist | 0.04 0.006 CID_5202 | CID_5202 | |
| 0.159 | 0.17 | 0.233 | Peptidyltransferase inhibitor | 0.233 0.064 CID_5202 | CID_5202 | |
| 0.033 | 0.045 | 0.041 | Urokinase inhibitor | 0.041 0.038 CID_5202 | CID_5202 | |
| 0.075 | 0.088 | 0.087 | Protein kinase C mu inhibitor | 0.087 0.071 CID_5202 | CID_5202 | |
| 0.052 | 0.066 | 0.073 | Carbonic anhydrase V inhibitor | 0.073 0.04 CID_5202 | CID_5202 | |
| 0.018 | 0.034 | 0.022 | ICAM 1 antagonist | 0.022 0.017 CID_5202 | CID_5202 | |
| 0.006 | 0.021 | 0.014 | Beta 3 adrenoreceptor agonist | 0.014 0.006 CID_5202 | CID_5202 | |
| 0.133 | 0.149 | 0.144 | EphB2 antagonist | 0.144 0.135 CID_5202 | CID_5202 | |
| 0.06 | 0.077 | 0.064 | MDM2 inhibitor | 0.064 0.059 CID_5202 | CID_5202 | |
| 0.083 | 0.099 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.073 CID_5202 | CID_5202 | |
| 0.01 | 0.027 | 0.017 | KiSS-1 receptor antagonist | 0.017 0.012 CID_5202 | CID_5202 | |
| 0.087 | 0.105 | 0.125 | Histone deacetylase class III inhibitor | 0.125 0.065 CID_5202 | CID_5202 | |
| 0.091 | 0.11 | 0.111 | Cholinergic antagonist | 0.111 0.083 CID_5202 | CID_5202 | |
| 0.089 | 0.108 | 0.108 | Acetylcholine antagonist | 0.108 0.082 CID_5202 | CID_5202 | |
| 0.033 | 0.052 | 0.044 | Neurotensin receptor antagonist | 0.044 0.032 CID_5202 | CID_5202 | |
| 0.131 | 0.152 | 0.153 | Succinate dehydrogenase inhibitor | 0.153 0.107 CID_5202 | CID_5202 | |
| 0.027 | 0.048 | 0.04 | Toll-Like receptor 2 agonist | 0.04 0.029 CID_5202 | CID_5202 | |
| 0.096 | 0.121 | 0.132 | Transcription factor STAT6 inhibitor | 0.132 0.042 CID_5202 | CID_5202 | |
| 0.039 | 0.064 | 0.142 | Alcohol oxidase inhibitor | 0.142 0.011 CID_5202 | CID_5202 | |
| 0.071 | 0.097 | 0.136 | Monophenol monooxygenase inhibitor | 0.136 0.053 CID_5202 | CID_5202 | |
| 0.053 | 0.079 | 0.202 | Porphobilinogen synthase inhibitor | 0.202 0.012 CID_5202 | CID_5202 | |
| 0.004 | 0.03 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 CID_5202 | CID_5202 | |
| 0.187 | 0.213 | 0.288 | Interleukin 2 agonist | 0.288 0.082 CID_5202 | CID_5202 | |
| 0.031 | 0.06 | 0.046 | Geranyltranstransferase inhibitor | 0.046 0.028 CID_5202 | CID_5202 | |
| 0.052 | 0.082 | 0.086 | Na+ K+ transporting ATPase inhibitor | 0.086 0.044 CID_5202 | CID_5202 | |
| 0.046 | 0.077 | 0.069 | Heat shock protein 90 beta antagonist | 0.069 0.029 CID_5202 | CID_5202 | |
| 0.141 | 0.172 | 0.156 | Vasodilator | 0.156 0.148 CID_5202 | CID_5202 | |
| 0.082 | 0.116 | 0.1 | Alkylator | 0.1 0.088 CID_5202 | CID_5202 | |
| 0.046 | 0.081 | 0.074 | NMDA receptor agonist | 0.074 0.033 CID_5202 | CID_5202 | |
| 0.051 | 0.087 | 0.063 | Protein kinase C alpha inhibitor | 0.063 0.055 CID_5202 | CID_5202 | |
| 0.058 | 0.095 | 0.09 | Ornithine decarboxylase inhibitor | 0.09 0.055 CID_5202 | CID_5202 | |
| 0.023 | 0.062 | 0.037 | Opioid delta receptor agonist | 0.037 0.023 CID_5202 | CID_5202 | |
| 0.123 | 0.164 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.138 0.082 CID_5202 | CID_5202 | |
| 0.046 | 0.088 | 0.067 | Catalase inhibitor | 0.067 0.057 CID_5202 | CID_5202 | |
| 0.061 | 0.104 | 0.124 | Opioid antagonist | 0.124 0.035 CID_5202 | CID_5202 | |
| 0.155 | 0.197 | 0.195 | Lipoxygenase inhibitor | 0.195 0.145 CID_5202 | CID_5202 | |
| 0.046 | 0.089 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.031 CID_5202 | CID_5202 | |
| 0.029 | 0.072 | 0.055 | Opioid mu receptor agonist | 0.055 0.026 CID_5202 | CID_5202 | |
| 0.115 | 0.16 | 0.136 | Interleukin 6 antagonist | 0.136 0.113 CID_5202 | CID_5202 | |
| 0.066 | 0.111 | 0.106 | Triose-phosphate isomerase inhibitor | 0.106 0.042 CID_5202 | CID_5202 | |
| 0.069 | 0.118 | 0.09 | Hematopoietic | 0.09 0.049 CID_5202 | CID_5202 | |
| 0.048 | 0.098 | 0.074 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.056 CID_5202 | CID_5202 | |
| 0.071 | 0.124 | 0.091 | Bile acid receptor antagonist | 0.091 0.07 CID_5202 | CID_5202 | |
| 0.038 | 0.091 | 0.105 | Opioid mu receptor antagonist | 0.105 0.03 CID_5202 | CID_5202 | |
| 0.052 | 0.107 | 0.085 | GABA aminotransferase inhibitor | 0.085 0.04 CID_5202 | CID_5202 | |
| 0.095 | 0.15 | 0.162 | Cell wall synthesis inhibitor | 0.162 0.054 CID_5202 | CID_5202 | |
| 0.031 | 0.086 | 0.102 | Opioid delta receptor antagonist | 0.102 0.029 CID_5202 | CID_5202 | |
| 0.149 | 0.206 | 0.212 | DNA synthesis inhibitor | 0.212 0.105 CID_5202 | CID_5202 | |
| 0.069 | 0.128 | 0.118 | Cystathionine beta-synthase inhibitor | 0.118 0.059 CID_5202 | CID_5202 | |
| 0.024 | 0.083 | 0.071 | NMDA receptor subunit 3B antagonist | 0.071 0.015 CID_5202 | CID_5202 | |
| 0.061 | 0.12 | 0.092 | Mediator release inhibitor | 0.092 0.079 CID_5202 | CID_5202 | |
| 0.027 | 0.092 | 0.042 | AICAR transformylase inhibitor | 0.042 0.034 CID_5202 | CID_5202 | |
| 0.062 | 0.133 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.068 CID_5202 | CID_5202 | |
| 0.083 | 0.156 | 0.143 | Interleukin 4 antagonist | 0.143 0.057 CID_5202 | CID_5202 | |
| 0.121 | 0.196 | 0.148 | Catenin beta inhibitor | 0.148 0.109 CID_5202 | CID_5202 | |
| 0.039 | 0.115 | 0.057 | CDC25B inhibitor | 0.057 0.056 CID_5202 | CID_5202 | |
| 0.142 | 0.221 | 0.202 | 12-Lipoxygenase inhibitor | 0.202 0.15 CID_5202 | CID_5202 | |
| 0.153 | 0.233 | 0.177 | Transcription factor STAT inhibitor | 0.177 0.173 CID_5202 | CID_5202 | |
| 0.018 | 0.098 | 0.045 | Oxytocin agonist | 0.045 0.027 CID_5202 | CID_5202 | |
| 0.019 | 0.102 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.013 CID_5202 | CID_5202 | |
| 0.005 | 0.088 | 0.04 | AMPA 1 receptor antagonist | 0.04 0.015 CID_5202 | CID_5202 | |
| 0.034 | 0.119 | 0.052 | Botulinum neurotoxin type A inhibitor | 0.052 0.051 CID_5202 | CID_5202 | |
| 0.026 | 0.115 | 0.05 | Argininosuccinate synthase inhibitor | 0.05 0.047 CID_5202 | CID_5202 | |
| 0.007 | 0.097 | 0.034 | Arginase inhibitor | 0.034 0.028 CID_5202 | CID_5202 | |
| 0.029 | 0.119 | 0.061 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.061 0.029 CID_5202 | CID_5202 | |
| 0.058 | 0.149 | 0.109 | Topoisomerase II inhibitor | 0.109 0.078 CID_5202 | CID_5202 | |
| 0.113 | 0.206 | 0.187 | Neurotrophic factor enhancer | 0.187 0.09 CID_5202 | CID_5202 | |
| 0.015 | 0.108 | 0.048 | NMDA receptor subunit 3A antagonist | 0.048 0.021 CID_5202 | CID_5202 | |
| 0.059 | 0.154 | 0.124 | Chelator | 0.124 0.05 CID_5202 | CID_5202 | |
| 0.052 | 0.146 | 0.117 | Alcohol dehydrogenase inhibitor | 0.117 0.037 CID_5202 | CID_5202 | |
| 0.009 | 0.104 | 0.03 | AMPA 3 receptor antagonist | 0.03 0.02 CID_5202 | CID_5202 | |
| 0.021 | 0.12 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.016 CID_5202 | CID_5202 | |
| 0.071 | 0.171 | 0.144 | Lipid peroxidase inhibitor | 0.144 0.072 CID_5202 | CID_5202 | |
| 0.088 | 0.19 | 0.125 | Heat shock protein 90 antagonist | 0.125 0.105 CID_5202 | CID_5202 | |
| 0.019 | 0.122 | 0.048 | Opioid agonist | 0.048 0.043 CID_5202 | CID_5202 | |
| 0.052 | 0.158 | 0.171 | Creatine kinase inhibitor | 0.171 0.017 CID_5202 | CID_5202 | |
| 0.04 | 0.16 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 CID_5202 | CID_5202 | |
| 0.045 | 0.166 | 0.081 | Opioid kappa receptor antagonist | 0.081 0.056 CID_5202 | CID_5202 | |
| 0.049 | 0.177 | 0.073 | Estrogen receptor alpha antagonist | 0.073 0.06 CID_5202 | CID_5202 | |
| 0.035 | 0.167 | 0.072 | Analgesic, opioid | 0.072 0.059 CID_5202 | CID_5202 | |
| 0.119 | 0.255 | 0.177 | MAP-kinase-activated kinase 5 inhibitor | 0.177 0.136 CID_5202 | CID_5202 | |
| 0.05 | 0.192 | 0.087 | Anabolic | 0.087 0.084 CID_5202 | CID_5202 | |
| 0.032 | 0.175 | 0.066 | Aminopeptidase I inhibitor | 0.066 0.059 CID_5202 | CID_5202 | |
| 0.05 | 0.199 | 0.112 | Glutamate receptor antagonist | 0.112 0.083 CID_5202 | CID_5202 | |
| 0.136 | 0.295 | 0.237 | Sodium/bile acid cotransporter inhibitor | 0.237 0.143 CID_5202 | CID_5202 | |
| 0.051 | 0.279 | 0.131 | Estrogen antagonist | 0.131 0.037 CID_5202 | CID_5202 | |
| 0.028 | 0.383 | 0.111 | Estrogen receptor beta antagonist | 0.111 0.044 CID_5202 | CID_5202 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |